Beyond the amyloidogenesis pathway, Zhang et al. demonstrated the potent inhibitory effects of CNDs and B-CDs on tau aggregation, with promising implications for delivering memantine to target AD pathology in the brain [27]. This evidence concerns the gene MAPT and Alzheimer disease.